The Reserve Bank of India (RBI) has criticized asset reconstruction companies (ARCs) for their use of distressed assets and innovative stru...

A key objective for us this year is to present our state's highly skilled talent pool, effective policies and robust infrastructure, and hi...

Jai Lala, CEO of Zenith India, confirmed the development. "We are delighted that Nestle has once again chosen us as their media partner and...

The method uses machine learning algorithms to detect defects of bananas prior to them being sold in the market. These algorithms are later...

“As part of this unique investment tool, the PCMC administration will only have to bear the costs of a public welfare project associated wi...

swissnex India coaches these early-stage and growth-stage startups on business pivot strategies, product or service localisation, market un...

The U.S. Food and Drug Administration on Wednesday approved a radical new one-time treatment from the Swiss drugmaker, weeks earlier than e...

PM’s panel on innovation has tasted its first success with the Indo-Japan deal and will now be working on projects in solar energy, roads a...

The chosen agency will have to come up with a separate creative strategy for a social media campaign and also manage the content on the por...

Developed countries are hungry to tap into the potential of India’s booming consumer market, which their paltry populations couldn't race t...

The SIT found and reported that there was no amount shown in almost 289 HSBC Geneva entries, while 122 of them were repeated twice in the s...

US Federal agency USITC today started a fact finding probe into impact of Indian trade and investment policies on the American economy.

Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India

The new TV campaign launched by Saatchi & Saatchi, India for the Swiss-pharma brand Novartis for the Otrivin cold tablets is an innovative ...

Domestic pharma major Wockhardt has decided to enter the lucrative contract manufacturing (CRAM) space from the next fiscal.

Hearings in Novartis’ appeal against the rejection of patent for its anti-cancer drug Glivec have been suspended yet again, after the Madra...

As the middle class witnesses rise in purchasing power, foreign accessory makers are coming to the country in a big way, the latest being S...